It’s not every day that medical advice shifts toward less medication, but a research letter out yesterday in the Annals of Internal Medicine says just that. An analysis of 2025 hypertension guidelines concludes that 11% of people 65 to 79 years old with stage 1 hypertension (130-139 mm/Hg for the top number or 80-90mm/Hg for the bottom) […]
Here’s who might not need to take blood pressure meds Read More »
That’s the age — down from 40 — at which people should start considering statins or other measures to manage cholesterol, according to new guidelines released Friday by leading medical organizations. The updated recommendations take a more sweeping approach for when and how to prevent and treat cardiovascular diseases caused by the hardening and narrowing
From left: The nutritionist, Rose Ferguson, Gwyneth Paltrow and Jennifer Aniston are all fans of peptides DAVE BENETT, MEGA, UNIQUE NICOLE/AFP/GETTY IMAGES Peta Bee Friday March 13 2026, 5.00am GMT, The Times Puzzles Challenge yourself with today’s puzzles. Crossword Polygon Sudoku We’ve all become familiar with jabs that reduce fat and erase wrinkles. Now there’s
Peptide injections: the celebs’ new favourite longevity jab Read More »
The discovery of an unusual protein on the surface of cancer cells may provide scientists with an ideal immunotherapy target for solid tumors, according to a study published yesterday in Science. Most immunotherapies work by drawing the immune system to a particular marker on the surface of a cancer cell in order to destroy those cells. This
‘Barfing’ cancer cells and the promise of an anomalous protein Read More »
The FDA on Tuesday approved a new indication for a drug that has long been generic to treat a rare brain disorder, O. Rose Broderick reports. The FDA approved GSK’s Wellcovorin (leucovorin calcium) in 1983 for other indications, including to lessen the toxicity of chemotherapy. The new approval adds an indication for cerebral folate deficiency. GSK no longer
FDA approves rare disease drug, kind of Read More »
By Maya Goldman Illustration: Lindsey Bailey/Axios The Trump administration is planning something new for people shopping on Affordable Care Act marketplaces next year: health plans without a list of in-network doctors and hospitals. Why it matters: The “non-network” plans could inject a dose of long-sought innovation into health care pricing. But they also could expose patients to more
Providerless plans could reshape ACA Read More »
Psychiatric disorders are common among people with epilepsy. But a new study, published yesterday in JAMA Neurology, pinpoints suicidal ideation and attempts as unique predictors of a person’s response to antiseizure medications. Among nearly 350 participants in the Human Epilepsy Project, experiencing suicidality — whether or not it was accompanied by a mood or anxiety disorder
Suicidality as a predictor of epilepsy med response Read More »
The cost of weight loss medications is on the way down, with Novo Nordisk slashing list prices for Ozempic and Wegovy to $675 — half their current costs — next year. Direct-to-consumer prices are even less. But the semaglutide drugs remains unaffordable for lots of people in the U.S. and elsewhere. A new analysis suggests
Generic Ozempic could be made for $28 a year, says analysis Read More »
After a steady stream of GLP-1 data last week, the news kept flowing this week when Sciwind Biosciences got clearance from Chinese regulators for its GLP-1 injectable for obesity. Pfizer will commercialize the drug in that country following a deal last month. But the obesity attention this week was more focused on the amylin front. The mechanism, which some
This week it’s amylin in the obesity race Read More »
Acetaminophen use in emergency departments for pregnant women plummeted in the wake of last year’s press conference in which President Trump and his health officials cautioned against the use of the drug, according to a new study published yesterday. Health officials said taking the painkiller increased the risk of having a kid with autism, even though the
The impact of Trump’s ‘Don’t take Tylenol’ Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866